skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Fragment-based discovery of a small molecule inhibitor of Bruton’s Tyrosine Kinase

Journal Article · · Journal of Medicinal Chemistry
 [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1]
  1. Takeda California, San Diego, CA (United States)
+ Show Author Affiliations

The discovery and optimization of a series of 4-aminocinnoline-3-carboxamide inhibitors of Bruton’s tyrosine kinase are reported. A fragment-based screening approach incorporating X-ray co-crystallography was used to identify a cinnoline fragment and characterize its binding mode in the ATP binding site of Btk. Optimization of the fragment hit resulted in the identification of a lead compound which reduced paw swelling in a dose- and exposure-dependent fashion in a rat model of collagen-induced arthritis.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
USDOE
OSTI ID:
1213735
Journal Information:
Journal of Medicinal Chemistry, Vol. 58, Issue 14; ISSN 0022-2623
Publisher:
American Chemical Society (ACS)Copyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 56 works
Citation information provided by
Web of Science

References (25)

Ligand efficiency: a useful metric for lead selection journal May 2004
The influence of drug-like concepts on decision-making in medicinal chemistry journal November 2007
Palladium-catalyzed inter- and intramolecular cross-coupling reactions of B-alkyl-9-borabicyclo[3.3.1]nonane derivatives with 1-halo-1-alkenes or haloarenes. Syntheses of functionalized alkenes, arenes, and cycloalkenes via a hydroboration-coupling sequence journal January 1989
The Genetic Program of Hematopoietic Stem Cells journal June 2000
Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis journal November 2011
The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy journal July 2010
The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages journal December 1993
RN486, a Selective Bruton's Tyrosine Kinase Inhibitor, Abrogates Immune Hypersensitivity Responses and Arthritis in Rodents journal January 2012
Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase journal January 2007
Purine derivatives as potent Bruton’s tyrosine kinase (BTK) inhibitors for autoimmune diseases journal May 2014
Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection journal December 2010
A role for Bruton's tyrosine kinase (Btk) in platelet activation by collagen journal October 1998
Finding the sweet spot: the role of nature and nurture in medicinal chemistry journal April 2012
Bruton's tyrosine kinase defect in dendritic cells from X-linked agammaglobulinaemia patients does not influence their differentiation, maturation and antigen-presenting cell function: DC differentiation and maturation in X-linked agammaglobulinaemia journal June 2003
The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells journal January 2011
Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia journal January 1993
Antiarthritis Effect of a Novel Bruton's Tyrosine Kinase (BTK) Inhibitor in Rat Collagen-Induced Arthritis and Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling: Relationships between Inhibition of BTK Phosphorylation and Efficacy journal April 2011
Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon Fc epsilon RI cross-linking. journal August 1994
An intrinsic but cell-nonautonomous defect in GATA-1-overexpressing mouse erythroid cells journal August 2000
Chemotactic Factor-induced Recruitment and Activation of Tec Family Kinases in Human Neutrophils journal June 2002
Specific Btk inhibition suppresses B cell– and myeloid cell–mediated arthritis journal November 2010
The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo journal July 2009
Structure-Based Drug Design of RN486, a Potent and Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor, for the Treatment of Rheumatoid Arthritis journal April 2014
Evolving concepts of rheumatoid arthritis journal May 2003
Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. journal January 1994

Cited By (11)

Targeting Bruton's tyrosine kinase for the treatment of B cell associated malignancies and autoimmune diseases: Preclinical and clinical developments of small molecule inhibitors journal May 2018
Cinnoline Scaffold—A Molecular Heart of Medicinal Chemistry? journal June 2019
Thermodynamic Insight into the Effects of Water Displacement and Rearrangement upon Ligand Modifications using Molecular Dynamics Simulations journal May 2018
Unprecedented synthesis of 1,2,3-triazolo-cinnolinone via Sonogashira coupling and intramolecular cyclization journal January 2018
Pharmacophore modeling and virtual screening in search of novel Bruton’s tyrosine kinase inhibitors journal June 2019
In depth analysis of kinase cross screening data to identify chemical starting points for inhibition of the Nek family of kinases journal January 2018
Novel 4-(1H-1,2,3-triazol-4-yl)methoxy)cinnolines as potent antibacterial agents: Synthesis and molecular docking study text January 2020
BindingDB Entry 50046163: Fragment-Based Discovery of a Small Molecule Inhibitor of Bruton's Tyrosine Kinase. dataset January 2016
Novel 4-(1H-1,2,3-triazol-4-yl)methoxy)cinnolines as potent antibacterial agents: Synthesis and molecular docking study journal February 2020
Water in protein hydration and ligand recognition journal August 2019
Recent Advances in Indazole-Containing Derivatives: Synthesis and Biological Perspectives journal October 2018

Similar Records

Small Molecule Reversible Inhibitors of Bruton’s Tyrosine Kinase (BTK): Structure–Activity Relationships Leading to the Identification of 7-(2-Hydroxypropan-2-yl)-4-[2-methyl-3-(4-oxo-3,4-dihydroquinazolin-3-yl)phenyl]-9 H -carbazole-1-carboxamide (BMS-935177)
Journal Article · Thu Sep 08 00:00:00 EDT 2016 · Journal of Medicinal Chemistry · OSTI ID:1213735
+28 more
Design and synthesis of carbazole carboxamides as promising inhibitors of Bruton’s tyrosine kinase (BTK) and Janus kinase 2 (JAK2)
Journal Article · Thu Oct 01 00:00:00 EDT 2015 · Bioorganic & Medicinal Chemistry Letters · OSTI ID:1213735
+12 more
Aminopyrazole Carboxamide Bruton’s Tyrosine Kinase Inhibitors. Irreversible to Reversible Covalent Reactive Group Tuning
Journal Article · Mon Dec 03 00:00:00 EST 2018 · ACS Medicinal Chemistry Letters · OSTI ID:1213735
+29 more

Related Subjects

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY